In the 1970s and 1980s, there were no therapies to treat MS. The first disease-modifying medication didn’t become available until 1993. Fast-forward to today when we have nearly 20 disease-modifying therapies, and more are being developed all the time. The Multiple Sclerosis Center Comprehensive Multiple Sclerosis Center joins other research facilities across the nation and around the world in developing and testing new protocols and therapies to help MS patients live longer, healthier lives. Taking part in groundbreaking MS research is a commitment we make not only to our current patients, but to the patients of tomorrow.

“Participating in clinical drug trials provides our patients with the opportunity to obtain promising new therapies long before they are available to the general public. This expands our ability to care for patients with Multiple Sclerosis, and includes our patients in the development of new and exciting therapies not previously available”.
Dr. Jeffrey Gitt

The first disease modifying medication for multiple sclerosis became available in 1993. Since then, research in this field has exploded. Because multiple sclerosis manifests differently from patient to patient, there isn’t one protocol that works for everyone. Even with the growing number of treatment options, there is always a need for more.

Our passion for helping patients with MS has led us to establish a dedicated research department in our Comprehensive Multiple Sclerosis Center. Drs Gitt, Hendin, and Travis have collectively served as primary investigators on hundreds of clinical trials related to MS, and this work will continue with the goal of providing more options and better treatments for patients here in Arizona and across the globe.

Taking part in a clinical trial not only gives you access to therapies that otherwise would not be available to you, it also allows you to be a part of something bigger– making life better for the MS patients who will come after you.

“Proper teaching and care and medication could change the trajectory from one of likely disability to one where we keep more and more people healthy and productive, delaying and even preventing disability.” — Dr. Barry A. Hendin


Bottom Contact